Skip to search formSkip to main contentSkip to account menu

Madopar

Known as: madopa, modopar 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

BenserazideBenserazide / LevodopaLevodopa

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Electrocatalytic oxidation and voltammetric determination of levodopa in the presence of carbidopa at the surface of a nanostructure based electrochemical sensor.
2009
2009
Complementary Acupuncture Treatment Increases Cerebral Metabolism in Patients with Parkinson's Disease
We used positron emission tomography (PET) and the 18-flourodeoxyglucose tracer to study cerebral effects of complementary… 
Highly Cited
2005
Highly Cited
2005
Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
In an open, uncontrolled study the longterm (9 years) effect of treatment with Madopar® alone (n=377) or in combination with l… 
Highly Cited
2005
Highly Cited
2005
The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
The potentiation of the ami akinetic effect after L-Dopa treatment by an inhibitor of monoamine oxidase (MAO) “B”, Deprenil, has… 
Highly Cited
1996
Highly Cited
1996
Sustained‐release Madopar HBS® compared with standard Madopar® in the long‐term treatment of de novo parkinsonian patients
In this Danish‐Norwegian randomized double‐blind parallel‐group multicentre study, we compared the therapeutic response of slow… 
1993
1993
Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease
1989
1989
Enantiomeric composition of urinary salsolinol in Parkinsonian patients after Madopar
SummaryUrinary salsolinol output had been shown to be lower in Parkinsonian patients than in controls and to increase largely… 
1987
1987
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
The combinations of benserazide and levodopa (1:4, Madopar) and of carbidopa and levodopa (1:10 and 1:4, Sinemet) are currently… 
Highly Cited
1979
Highly Cited
1979
Distinction between benign and malignant type of parkinson's disease
Highly Cited
1977
Highly Cited
1977
IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE A Long-term Study
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License